MariMed Inc (MRMD)
0.295
+0.01
(+1.94%)
USD |
OTCM |
May 07, 15:43
MariMed Revenue (Quarterly): 38.90M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 38.90M |
| September 30, 2023 | 38.80M |
| June 30, 2023 | 36.52M |
| March 31, 2023 | 34.38M |
| December 31, 2022 | 35.83M |
| September 30, 2022 | 33.91M |
| June 30, 2022 | 32.99M |
| March 31, 2022 | 31.28M |
| December 31, 2021 | 31.04M |
| September 30, 2021 | 33.21M |
| June 30, 2021 | 32.57M |
| March 31, 2021 | 24.64M |
| December 31, 2020 | 20.36M |
| September 30, 2020 | 13.46M |
| June 30, 2020 | 9.610M |
| March 31, 2020 | 7.466M |
| December 31, 2019 | 5.192M |
| September 30, 2019 | 11.22M |
| June 30, 2019 | 25.67M |
| March 31, 2019 | 3.516M |
| December 31, 2018 | 3.440M |
| September 30, 2018 | 3.392M |
| June 30, 2018 | 2.937M |
| March 31, 2018 | 2.083M |
| December 31, 2017 | 1.580M |
| Date | Value |
|---|---|
| September 30, 2017 | 1.716M |
| June 30, 2017 | 1.621M |
| March 31, 2017 | 1.151M |
| December 31, 2016 | 1.429M |
| September 30, 2016 | 0.8735M |
| June 30, 2016 | 0.6474M |
| March 31, 2016 | 0.6145M |
| December 31, 2015 | 0.7266M |
| September 30, 2015 | 0.3928M |
| June 30, 2015 | 0.0545M |
| March 31, 2015 | 0.0962M |
| December 31, 2014 | 0.0877M |
| September 30, 2014 | 0.0002M |
| June 30, 2014 | 0.0002M |
| March 31, 2014 | 0.0002M |
| December 31, 2013 | 0.0002M |
| September 30, 2013 | 0.0004M |
| June 30, 2013 | 0.0001M |
| March 31, 2013 | 0.0002M |
| December 31, 2012 | 0.0001M |
| September 30, 2012 | 0.0002M |
| June 30, 2012 | 0.0002M |
| March 31, 2012 | 0.0002M |
| September 30, 2011 | 0.0252M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
5.192M
Minimum
Dec 2019
38.90M
Maximum
Dec 2023
26.16M
Average
31.28M
Median
Mar 2022
Revenue (Quarterly) Benchmarks
| Emergent BioSolutions Inc | 292.40M |
| Zymeworks Inc | 10.03M |
| Viemed Healthcare Inc | 50.74M |
| NovaBay Pharmaceuticals Inc | 3.727M |
| Palatin Technologies Inc | 2.034M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.17M |
| Total Expenses (Quarterly) | 36.20M |
| EPS Diluted (Quarterly) | -0.02 |
| Enterprise Value | 159.78M |
| Gross Profit Margin (Quarterly) | 44.52% |
| Profit Margin (Quarterly) | -26.14% |
| Earnings Yield | -11.71% |
| Operating Earnings Yield | 14.18% |
| Normalized Earnings Yield | -3.678 |